Abstract:Introduction Sudden cardiac death (SCD) in athletes is a devastating, highly publicized event that sparks ongoing debate and research into identifying potential risk factors, and its preventative screening is a controversial topic among cardiologists. With the lack of a world-renowned screening program model for athletes, the need for an adequate one is compelling. Several cases of sudden death in young Jordanian athletes were reported in the news, with no comprehensive data on SCDs. Thus, it is difficult to quantify the scope of the problem, making it all the more imperative to address this matter. This paper aims to shed light on a potential comprehensive universal cardiovascular screening model that could reduce the prevalence of SCD in athletes, focusing on its potential applicability in Jordan. Incidence Studies show a strong relationship between athleticism and the risk of SCD. In the UK, over 7,675 cases of SCD were reported by the national cardiac pathology center from 1994 to June 2022. American student-athletes were found to be 3.6 times more likely to face SCD compared to their non-athletic counterparts. Startlingly, up to 80% of athletes who suffered SCD had no prior warning manifestations. Etiology Hypertrophic cardiomyopathy (HCM), arrhythmogenic cardiomyopathy, and familial long QT syndrome are the most extensively studied conditions that may cause SCD. In the US, Autopsy-negative sudden unexplained death and the lack of mandatory pre-participation cardiac screening (PPCS) account for a significant proportion of SCDs in athletes. Current Methods & Limitations Current screening protocols have limited efficacy in detecting cardiovascular disease (CVD) in athletes. The American Heart Association (AHA) protocol involves a 14-point history and a physical exam (H&P), while European and other sporting societies recommend using ECG. However, a screening protocol rooted in H&P alone resulted in a high number of false negative results, with a sensitivity as low as ∼20%. Another limitation is having underreported symptoms due to familial and societal pressures to perform. Without an echocardiogram, some electrically silent pathologies can be missed. Our Proposed Model Including an echocardiogram in the screening of athletes can bring a more comprehensive form of evaluation to the PPCS program, particularly in countries where it is not as costly, such as Jordan. Additionally, using ECG could raise the sensitivity of CVD detection by 45.4%, as demonstrated in the UAE. This proposed model is a program unified for all athletes, with more elements than what is provided in the literature, which ensures reaching a proper diagnosis, regardless of expertise.

Value of preparticipation cardiovascular evaluation of master athletes by self-reported symptoms and cardiovascular risk-score

Cardiovascular evaluation of middle-aged individuals engaged in high-intensity sport activities: implications for workload, yield and economic costs

Cardiovascular Risk Profile in Master Paralympic Athletes, a High-Risk Undertreated Population: A Cross-Sectional Longitudinal Study

Pre-Participation Screenings Frequently Miss Occult Cardiovascular Conditions in Apparently Healthy Male Middle-Aged First-Time Marathon Runners

ECG SCREENING, HEART RATE VARIABILITY AND SUDDEN CARDIAC DEATH PREVENTION IN ENDURANCE ATHLETES

The role of coronary CT angiography in athletes

Prevalence of electrocardiographic markers associated with myocardial fibrosis in masters athletes: a cohort study

[Race against sudden death : the benefits of pre-participation cardiovascular screening]

Sudden Cardiac and Noncardiac Death in Sports: Epidemiology, Causes, Pathogenesis, and Prevention

The Way To An Athlete's Heart; The Ideal Cardiac Screening Program

Pathophysiology, Risk Stratification, and Sports Eligibility Assessment

Causes of sudden cardiac arrest and death and the diagnostic yield of sport preparticipation screening in children

Exercise ECG Testing and Stress Cardiac Magnetic Resonance for Risk Prediction in Patients With Chronic Coronary Syndrome

A novel risk score based on exercise capacity to predict all-cause mortality in adults with congenital heart disease

Abstract 12668: Prevalence of Phenotypic Hypertrophic Cardiomyopathy Among Students Referred for Sport Pre-Participation Cardiovascular Screening

Preparticipation Cardiovascular Screening of Athletes: Current Controversies and Challenges for the Future

Let It Beat: How Lifestyle and Psychosocial Factors Affect the Risk of Sudden Cardiac Death—A 10-Year Follow-Up Study

Accuracy of a non‐exercise method using seismocardiography for the estimation of V̇O2peak in sub‐elite football players

Ideal Cardiovascular Health and the Prevalence and Severity of Aortic Stenosis in Elderly Patients.

Aspirin to Prevent Sudden Cardiac Death in Athletes with High Coronary Artery Calcium Scores

The Spectrum of Coronary Artery Disease in Elite Endurance Athletes-A Long-Standing Debate: State-of-the-Art Review